Adult patients with primary hyperlipidemia and mixed dyslipideima
as an adjuvant diet to reduce elevated total -C, LDL -C, ApoB, non HDL - C,
and TG levels and to increase HDL - C levels
Pediatric patients 8 to 17 years of age with heterozygous familiar
hypercholesterolemia to reduce elevated total - C, LDL -C and ApoB after
failing adequate trail of diet therapy
Pediatric patients 7 to 17 years of age with homozygous familiar
hypercholesterolemia to reduce LDL -C, total - C, non HDL - C and Apo B as an
adjuvant to diet either alone or with other lipid lowering treatments
Adult patients with hypertriglycerdemia as an adjuvant to diet,
Adult patient with primary dysbetalipoprotinemia as an adjuvant to diet,
Adult patient with homozygous familiar hypercholesterolemia to reduce LDL - C,
total C and ApoB
Slowing the progress of atherosclerosis as part of a treatment strategy
to lower total - C and LDL - C as an adjuvant to diet, Risk reduction of MI ,
Stroke and aterial revascularization procedures in patient
without clinically evident CHD but with multiple risk factors
